{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:23:30Z","timestamp":1762507410471,"version":"3.37.3"},"reference-count":6,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T00:00:00Z","timestamp":1527120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1111\/bcp.13617","type":"journal-article","created":{"date-parts":[[2018,5,25]],"date-time":"2018-05-25T04:29:31Z","timestamp":1527222571000},"page":"1858-1859","source":"Crossref","is-referenced-by-count":6,"title":["Desogestrel and panic attacks \u2013 a new suspected adverse drug reaction reported by patients and health care professionals on spontaneous reports"],"prefix":"10.1111","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9660-5968","authenticated-orcid":false,"given":"Sarah","family":"Watson","sequence":"first","affiliation":[{"name":"Uppsala Monitoring Centre  Uppsala Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"H\u00e4rmark","sequence":"additional","affiliation":[{"name":"The Netherlands Pharmacovigilance Centre Lareb  's\u2010Hertogenbosch The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,5,24]]},"reference":[{"key":"e_1_2_3_2_1","unstructured":"Electronic medicines compendium: summary of product characteristics for desogestrel (Cerazette\u00ae). Available athttps:\/\/www.medicines.org.uk\/emc\/medicine\/10098(last accessed 10 November 2017)."},{"key":"e_1_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/009286150804200501"},{"key":"e_1_2_3_4_1","unstructured":"Caveat document; accompanying statement to data released from VigiBase the WHO international database of suspected adverse drug reactions. Available athttps:\/\/www.who\u2010umc.org\/media\/1417\/umc_caveat_201605.pdf(last accessed 10 November 2017)."},{"volume-title":"Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM\u20105)","year":"2013","key":"e_1_2_3_5_1"},{"key":"e_1_2_3_6_1","first-page":"57","article-title":"Shrinkage observed\u2010to\u2010expected ratios for robust and transparent large\u2010scale pattern discovery","volume":"22","author":"Nor\u00e9n GN","year":"2013","journal-title":"Drug Saf"},{"key":"e_1_2_3_7_1","first-page":"478","article-title":"J Norplant\u2010associated major depression and panic disorder","volume":"55","author":"Wagner KD","year":"1994","journal-title":"Clin Psychiatry"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbcp.13617","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bcp.13617","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T14:55:45Z","timestamp":1694962545000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/bcp.13617"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,24]]},"references-count":6,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["10.1111\/bcp.13617"],"URL":"https:\/\/doi.org\/10.1111\/bcp.13617","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"type":"print","value":"0306-5251"},{"type":"electronic","value":"1365-2125"}],"subject":[],"published":{"date-parts":[[2018,5,24]]}}}